Please login to the form below

Not currently logged in
Email:
Password:

Human Papilloma Virus

This page shows the latest Human Papilloma Virus news and features for those working in and with pharma, biotech and healthcare.

Cancer jab 'unlikely' to have caused death

The injection is part of a national immunisation programme to protect girls against the two strains of human papilloma virus (HPV) that cause more than 70 per cent of cervical cancer

Latest news

  • Boots pilots cervical cancer vaccine

    The vaccination helps protect against the most common cancer-causing types of Human Papilloma Virus (HPV), but it does not protect against all the cancer-causing viruses, so women will still

  • R&D news in brief

    Advance in search for cervical cancer vaccine. Scientists have made ground in the search for a cervical cancer vaccine by unravelling the body's immune response to the virus. ... A study by the University of Birmingham, published in the British Journal

  • Quantum leap

    cancer. Results published on October 6 suggest that the vaccine, Gardasil, administered in three doses over six months was 100 per cent successful at protecting against two types of human papilloma ... virus (HPV), which are present in 70 per cent of

  • New cervical cancer vaccine on trial

    The Queensland scientist behind the technology, former Australian of the Year Professor Ian Frazer, said the vaccine had exciting potential to offer protection from more strains of the sexually-transmitted human ... papilloma virus (HPV).

  • HPV vaccination programme to start in England

    From September 2008, girls aged between 12 and 13 years in England will be vaccinated against the human papilloma virus (HPV). ... Approximately 80 per cent of sexually active women can expect to have an HPV infection at some point in their lives and the

More from news
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    The case of Human Papilloma Virus. 2006 and 2007 saw the first worldwide approvals of vaccines designed to immunise women and girls in particular against certain strains of the sexually transmitted ... human papilloma virus (HPV), including strains that

  • Pharma deals in August 2015 Pharma deals in August 2015

    This was the fifth deal announced by AstraZeneca/Medimmune in the month under which the company gained access to INO-3112 a cancer vaccine which targets cancers caused by human papilloma ... Exclusive commercial licence. 165. Cytos Biotechnology.

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Understanding the "Big Picture"

    A good example of this “Risk-awareness thinking” would be the impact of the cervical cancer vaccine to address human papilloma virus (HPV).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics